Treatment of tardive pharyngolaryngeal dystonia with olanzapine.
Havaki-Kontaxaki
Beata J
BJ
Kontaxakis
Vassilis P
VP
Christodoulou
George N
GN
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D004421:Dystonia / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007830:Larynx / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010614:Pharynx / Q000503:physiopathology*; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine